Innovation medicine sector surged in the short term, Harbin Pharmaceutical Group rose to the daily limit.

The innovative pharmaceutical sector made a quick rally, with Haikou Pharmaceuticals rising to the daily limit. Frontline Biotech, Double Crane Pharmaceuticals, XinGanjiang Pharmaceuticals, Yuet Kang Pharmaceuticals, Shu Tai Shen, and others followed suit.